Bed Calculator Eqd2

Use this interactive radiobiology calculator to estimate biologically effective dose (BED) and equivalent dose in 2 Gy fractions (EQD2) from any fractionation schedule. Enter total dose, fractions, or dose per fraction, choose an alpha/beta value, and compare how different regimens translate to a common biologic scale.

Calculator

Dose per fraction

2.00 Gy

BED

72.00 Gy

EQD2

60.00 Gy

Formula used: BED = n × d × (1 + d / (alpha/beta)). EQD2 = BED / (1 + 2 / (alpha/beta)). These equations come from the linear-quadratic framework and are widely used for fractionation comparisons, not as a substitute for physician judgment.

What is a BED calculator EQD2 tool?

A BED calculator EQD2 tool is a radiobiology utility used to compare different radiation therapy fractionation schedules on a common biological basis. In day-to-day oncology practice, prescriptions may be delivered as conventional 2 Gy fractions, moderate hypofractionation, stereotactic regimens, or even re-irradiation courses. Looking only at the physical dose can be misleading because 40 Gy in 5 fractions does not produce the same biological effect as 40 Gy in 20 fractions. That is where the concepts of biologically effective dose, or BED, and equivalent dose in 2 Gy fractions, or EQD2, become valuable.

BED estimates the biologic effect of a course by combining total dose and dose per fraction through the linear-quadratic model. EQD2 takes the next step and converts that effect into the notional total dose that would produce a similar result if it were given in 2 Gy fractions. Because many historical treatment regimens and tolerance references are framed around 2 Gy fractionation, EQD2 is often used as a common comparison language among radiation oncologists, medical physicists, dosimetrists, and trainees.

Why BED and EQD2 matter in clinical decision-making

The biggest strength of BED and EQD2 is standardization. They let clinicians compare schedules that would otherwise be hard to evaluate side by side. For example, if one schedule gives 70 Gy in 35 fractions and another gives 60 Gy in 20 fractions, the physical doses alone do not reveal which has the larger expected biological effect. BED and EQD2 can make that comparison transparent.

These metrics are particularly useful in several settings:

• Hypofractionation: As larger fraction sizes become common in breast, prostate, and palliative radiotherapy, BED and EQD2 help translate those regimens into a familiar framework.
• Normal tissue tolerance assessment: Organs at risk may respond differently depending on the alpha/beta ratio, so a biologic comparison can be more informative than physical dose alone.
• Re-irradiation discussions: Prior and planned courses can be translated into EQD2 to estimate cumulative biologic exposure, though this must be interpreted cautiously.
• Tumor control analysis: BED is often used in the literature when comparing local control outcomes across multiple dose-fractionation schedules.

The formulas behind the calculator

The standard linear-quadratic equations used in this calculator are:

1. BED = n × d × (1 + d / (alpha/beta))
2. EQD2 = BED / (1 + 2 / (alpha/beta))

In these formulas, n is the number of fractions and d is the dose per fraction in Gy. The alpha/beta ratio describes how sensitive a tissue or tumor is to fraction size. A higher alpha/beta ratio means less sensitivity to changes in fraction size, while a lower alpha/beta ratio means greater fraction-size sensitivity.

Interpreting alpha/beta values

Alpha/beta is not a universal constant for all tissues. It is a modeling parameter, and the selected value can materially change the result. Common practical assumptions include:

• 10 Gy: Often used for rapidly proliferating tissues and many tumors.
• 3 Gy: Commonly used for late-responding normal tissues.
• 1.5 Gy: Frequently cited in prostate radiobiology discussions.

If you calculate BED and EQD2 with a tumor alpha/beta of 10 Gy and then repeat the same plan with a late-responding tissue alpha/beta of 3 Gy, the numbers may differ significantly. That difference is exactly why radiobiologic context matters.

Worked examples

Example 1: Conventional fractionation

Suppose a patient receives 60 Gy in 30 fractions. The dose per fraction is 2 Gy. Using an alpha/beta ratio of 10 Gy:

• BED = 30 × 2 × (1 + 2/10) = 60 × 1.2 = 72 Gy
• EQD2 = 72 / 1.2 = 60 Gy

This makes intuitive sense: if the schedule already uses 2 Gy fractions, the EQD2 equals the original total dose.

Example 2: Moderate hypofractionation

Consider 60 Gy in 20 fractions, which corresponds to 3 Gy per fraction. At alpha/beta = 10 Gy:

• BED = 20 × 3 × (1 + 3/10) = 60 × 1.3 = 78 Gy
• EQD2 = 78 / 1.2 = 65 Gy

Even though the physical total dose is still 60 Gy, the biologic effect relative to 2 Gy fractions is higher.

Example 3: Same schedule, different tissue assumption

Now take that same 60 Gy in 20 fractions, but evaluate it using alpha/beta = 3 Gy:

• BED = 20 × 3 × (1 + 3/3) = 60 × 2 = 120 Gy
• EQD2 = 120 / (1 + 2/3) = 120 / 1.6667 = about 72 Gy

This demonstrates why larger fraction sizes can be much more impactful for fraction-sensitive tissues.

Comparison table: common fractionation patterns

The table below shows how several common schedules compare when evaluated with an alpha/beta ratio of 10 Gy. Values are rounded for readability.

Schedule	Dose per fraction	BED10	EQD2(10)	Clinical interpretation
50 Gy in 25 fractions	2.0 Gy	60.0 Gy	50.0 Gy	Baseline conventional example with EQD2 equal to physical dose.
60 Gy in 30 fractions	2.0 Gy	72.0 Gy	60.0 Gy	Standard conventional schedule often used as a reference point.
60 Gy in 20 fractions	3.0 Gy	78.0 Gy	65.0 Gy	Higher biologic intensity than 60 Gy in 30 fractions for alpha/beta 10.
40 Gy in 15 fractions	2.67 Gy	50.7 Gy	42.2 Gy	Common moderate hypofractionation pattern in selected settings.
30 Gy in 10 fractions	3.0 Gy	39.0 Gy	32.5 Gy	Often used in palliation where convenience is prioritized.

Comparison table: effect of alpha/beta selection on the same regimen

One of the most important lessons in radiobiology is that the chosen alpha/beta ratio can change interpretation. Below is the same schedule, 36.25 Gy in 5 fractions, analyzed with different alpha/beta values.

Schedule	Alpha/beta ratio	BED	EQD2	What it suggests
36.25 Gy in 5	10 Gy	62.5 Gy	52.1 Gy	Substantial tumor-effective dose, but interpretation depends on disease site and context.
36.25 Gy in 5	3 Gy	123.9 Gy	74.4 Gy	Much stronger effect predicted for late-responding tissue due to larger fraction size.
36.25 Gy in 5	1.5 Gy	211.5 Gy	90.6 Gy	Very high EQD2 under a low alpha/beta assumption, often discussed in prostate modeling.

Important limitations of a BED calculator EQD2 model

Although BED and EQD2 are powerful tools, they are not perfect. The linear-quadratic model is a simplification of biology, and its reliability may vary, especially at very high dose per fraction. In stereotactic radiosurgery and stereotactic body radiation therapy, some clinicians still use BED and EQD2 for rough comparisons, but they recognize that vascular effects, immune interactions, repair kinetics, and volume effects may not be fully captured by the model.

Additional limitations include:

• No direct account of overall treatment time unless a time-corrected model is added.
• No direct incorporation of repopulation, repair half-times, hypoxia, or spatial dose heterogeneity.
• Dependence on alpha/beta assumptions that may vary across studies and patient populations.
• Not a substitute for clinical constraints from protocol documents, QUANTEC-style reviews, or institutional standards.

How to use this calculator responsibly

A practical approach is to use the calculator as a decision-support aid, not a decision-maker. Start by entering the total dose and fractions. If you already know the dose per fraction, you can enter that directly. Then choose the alpha/beta ratio that fits your question. If you are comparing tumor effect, a higher alpha/beta may be appropriate. If you are evaluating late normal tissue risk, use a lower alpha/beta value that better reflects fraction sensitivity.

When interpreting the output, ask three questions:

1. What tissue or endpoint am I trying to model?
2. Is the chosen alpha/beta ratio defensible for that endpoint?
3. Does the plan fall within known clinical evidence, protocol guidance, and organ-at-risk tolerances?

For educational use, the calculator is excellent for understanding how larger dose per fraction increases BED, especially in tissues with low alpha/beta ratios. For clinical use, it should be considered alongside contouring accuracy, delivered dose distribution, prior treatment history, normal tissue volume effects, and peer-reviewed evidence.

Authoritative references and educational resources

If you want deeper background, these sources are helpful:

• National Cancer Institute (.gov): Radiation Therapy overview
• NCBI Bookshelf (.gov): Radiation biology and treatment principles
• University of Utah (.edu): Radiation oncology tutorial resources

Bottom line

A bed calculator eqd2 tool is one of the most useful ways to translate complex fractionation schedules into a shared biologic language. BED estimates the effect of a regimen, while EQD2 converts that effect into the equivalent total dose delivered in 2 Gy fractions. Together, they support schedule comparison, hypofractionation review, and re-irradiation discussions. Their value is highest when the user understands the assumptions behind the math, especially the importance of alpha/beta selection and the limitations of the linear-quadratic model.

If you are a clinician, physicist, dosimetrist, resident, or student, use the calculator to explore how changing fractions and dose per fraction changes the biologic story. Just remember that numbers from any radiobiology model must always be interpreted within the larger clinical picture.

This calculator is for educational and planning support purposes only. It does not provide medical advice and should not be used as the sole basis for prescribing radiation. Final treatment decisions require review by qualified radiation oncology professionals.